CD8A and neoplasm: Interaction of HSP70 with the co-stimulatory molecule CD40, promotes activation of CD8+ cytotoxic T cells [58], while the interaction of HSP90 and GP96 with CD91 on DCs contributes to cross-presentation of tumor antigens to cytotoxic T cells, possibly potentiated by TLR2 and TLR4 [59].